Bora Biologics Holdings, LLC Announces Cash Capital Increase for Subsidiary Bora Biologics USA, LLC
Bora Biologics Holdings, LLC, a subsidiary of Powertech, announced a cash capital increase of USD 86… · 2026-06-18
Bora Biologics Holdings, LLC, a subsidiary of Powertech, announced a cash capital increase of USD 86… · 2026-06-18
Hwalee announced on June 18, 2026, that its endorsement guarantee balance to its indirectly 100%-own… · 2026-06-18
Baorui announced on June 18, 115, that it has increased guarantees to its wholly-owned subsidiary Bo… · 2026-06-18
Far Eastern Biotech has announced a new endorsement guarantee of NT$947.4 million to its indirect su… · 2026-06-18
Baorui has announced the renewal of its Fourth Audit Committee due to term expiration, with new memb… · 2026-06-18
Pouyue announces changes to its Sustainable Development Committee due to the expiration of directors… · 2026-06-18
Baorui announced on 115/06/18 the appointment of new members to its Sixth Compensation Committee. Li… · 2026-06-18
Far Eastern Biotech and its subsidiaries have extended loans totaling NT$4.94 billion to affiliated … · 2026-06-18
Bora Pharmaceuticals USA Inc., a key subsidiary of Polpharma, has announced a cash capital increase … · 2026-06-18
Bora Pharmaceutical Holdings, LLC, a significant subsidiary of Powarui, has acquired the U.S. regula… · 2026-06-18
Bora Global Ltd., a subsidiary of Bora, has provided a loan of NT$2.57 billion to its U.S. subsidiar… · 2026-06-18
Bora Pharmaceuticals has been invited to participate in the GS China Healthcare Corporate Day event … · 2026-06-10
BORA's subsidiary, TWi Pharmaceuticals USA, Inc., announced a loan of approximately NT$411.71 millio… · 2026-06-10
Bora announced key resolutions passed at its 115th Annual General Meeting of Shareholders. These inc… · 2026-06-09
Bora has been invited by Yuanta Securities to participate in the Q2 2026 Investment Forum, holding a… · 2026-06-09
Cosmos Pharmaceuticals' Board of Directors resolved on June 9, 115 (2026) to re-elect Mr. Sheng Bao-… · 2026-06-09
Bora Pharmaceuticals announced that its shareholders' meeting approved the waiver of non-competition… · 2026-06-09
Bora Pharmaceuticals announced on June 9, 115, the results of its full board election following the … · 2026-06-09
Prorize announced its participation in the Q2 2026 Investment Forum hosted by First Golden Securitie… · 2026-06-03
Prorize announced its participation in the Q2 2026 Investment Forum hosted by First Golden Securitie… · 2026-06-03
Bora Pharmaceuticals announced that on May 20, 2026, it completed the registration for a capital red… · 2026-05-21
Bora Corporation's subsidiary, Bora Pharmaceuticals Inc., has signed a 10-year long-term contract ma… · 2026-05-18
Bora's subsidiary, Bora Pharmaceuticals Inc., has signed a 10-year long-term manufacturing agreement… · 2026-05-18
Bora Pharmaceutical announced that it will hold its Q1 2026 Online English Institutional Investor Co… · 2026-05-14
Bora Pharmaceutical announced that it will hold its Q1 2026 Online English Institutional Investor Co… · 2026-05-14
Bora Pharmaceuticals announced that its endorsement/guarantee balance for its subsidiary, Upsher-Smi… · 2026-05-13
Bora Pharmaceuticals Co., Ltd. announced that its board of directors resolved on May 13, 2026 to rep… · 2026-05-13
Bora Pharmaceuticals Co., Ltd. announced that its board of directors resolved on May 13, 2026 to rep… · 2026-05-13
Bora Pharmaceuticals announced its Q1 2026 consolidated financial results approved by the Board. For… · 2026-05-13
Bora announced that it has been invited by Taishin Securities to hold an institutional investor conf… · 2026-05-13
Bora announced that it has been invited by Taishin Securities to hold an institutional investor conf… · 2026-05-13
Bora Pharmaceuticals announced its Q1 2026 consolidated financial results approved by the Board. For… · 2026-05-13
Bora Pharmaceutical announced that its endorsement guarantee balance to its subsidiary, Bora Global … · 2026-05-13
Bora Pharmaceutical announced that its endorsement guarantee balance to its subsidiary, Bora Global … · 2026-05-13
Bora Pharmaceuticals announced that its endorsement/guarantee balance for its subsidiary, Upsher-Smi… · 2026-05-13
Bora announced on May 11, 2026, an increase in its subsidiary endorsement and guarantee balances, wi… · 2026-05-11
Bora is acquiring CDMO operating assets in Maryland, USA, for USD 122.5 million through its newly es… · 2026-05-11
Bora announces an increased guarantee for its subsidiary Bora Biologics USA LLC, amounting to approx… · 2026-05-11
Bora announced a USD 122.5 million cash capital increase for its subsidiary Bora Pharmaceuticals USA… · 2026-05-11
Bora Pharmaceuticals announced that as of May 11, 2026, its total endorsement guarantee balance for … · 2026-05-11
Bora is acquiring CDMO operating assets in Maryland, USA, for USD 122.5 million through its newly es… · 2026-05-11
Bora announces an increased guarantee for its subsidiary Bora Biologics USA LLC, amounting to approx… · 2026-05-11
Bora announced a USD 122.5 million cash capital increase for its subsidiary Bora Pharmaceuticals USA… · 2026-05-11
Bora has been invited by Yuanta Securities to participate in the Q2 2026 Investment Forum, holding a… · 2026-05-05
Baorui Company expects to hold its board meeting on May 13, 2026, to review the Q1 consolidated fina… · 2026-05-05
Baorui's board of directors has resolved to repurchase and cancel restricted employee stock options … · 2026-05-05
Baorui Company expects to hold its board meeting on May 13, 2026, to review the Q1 consolidated fina… · 2026-05-05
Baorui's board of directors has resolved to repurchase and cancel restricted employee stock options … · 2026-05-05
Poray announced that its subsidiary, Poray Management Consulting Co., Ltd., will subscribe to privat… · 2026-05-05
Poray announced that its subsidiary, Poray Management Consulting Co., Ltd., will subscribe to privat… · 2026-05-05
Poray announced its board of directors has approved a cash capital increase for its wholly-owned sub… · 2026-05-05
Poray's board of directors has set May 5, 2026, as the base date for a capital increase through the … · 2026-05-05
Poray's board of directors has set May 5, 2026, as the base date for a capital increase through the … · 2026-05-05
Poray announced its board of directors has approved a cash capital increase for its wholly-owned sub… · 2026-05-05
Bora Pharmaceuticals announced its May 2026 revenue of NTD 2,114,486 thousand (approx. NTD 2.11 bill… · 2026-05-01
Bora Pharmaceuticals announced its monthly revenue for April 2026 was NT$1.484 billion. This represe… · 2026-04-01
Bora Pharmaceuticals announced its monthly revenue for April 2026 was NT$1.484 billion. This represe… · 2026-04-01
Boray's Board of Directors has resolved to hold the annual general meeting of shareholders on June 9… · 2026-03-31
Boray's Board of Directors has resolved to hold the annual general meeting of shareholders on June 9… · 2026-03-31
Boray (Stock Code: 6472), a company in the biotech and healthcare sector, reported its March 2026 re… · 2026-03-01
Boray (Stock Code: 6472), a company in the biotech and healthcare sector, reported its March 2026 re… · 2026-03-01
Bora Pharmaceuticals released its revenue report for February 2026, posting NT$1.326 billion, a 23.2… · 2026-02-01
Bora Pharmaceuticals released its revenue report for February 2026, posting NT$1.326 billion, a 23.2… · 2026-02-01